SOPHiA GENETICS SA·4

Apr 16, 4:03 PM ET

Muken Ross 4

Research Summary

AI-generated summary

Updated

SOPHiA GENETICS (SOPH) President Muken Ross Sells 2,800 Shares

What Happened

  • Muken Ross, President of SOPHiA GENETICS SA, sold 2,800 ordinary shares in an open-market transaction on April 14, 2026. The weighted-average sale price was $4.96 per share for a total proceeds of $13,887.
  • This was a sale (S) executed to satisfy tax withholding related to restricted stock units that vested earlier in April; such sales are often routine and do not necessarily signal a change in view on the company.

Key Details

  • Transaction date: 2026-04-14; Form 4 filed 2026-04-16 (timely within required window).
  • Quantity and price: 2,800 shares sold at a weighted average price of $4.96; sale prices ranged between $4.75 and $5.16 (weighted avg reported).
  • Total proceeds reported: $13,887.
  • Footnotes: F1 — shares sold to satisfy tax withholding from RSU vesting on April 2 and 3, 2026; F1 also notes the trades were effected under a pre-established Rule 10b5-1(c) trading plan and were non-discretionary. F2 — issuer/staff may request breakdown of number of shares sold at each separate price within the stated range.
  • Shares owned after the transaction: not specified in the provided filing excerpt.

Context

  • Sales made solely to cover tax withholding on vested awards are common and treated as administrative transactions (often coded F for tax withholding in reporting). They provide less insight into the insider’s view than open-market purchases.
  • For retail investors, purchases by insiders tend to be more informative than routine sales like this one.